Correlation Between Pharvaris and Gilead Sciences

Can any of the company-specific risk be diversified away by investing in both Pharvaris and Gilead Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Gilead Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharvaris BV and Gilead Sciences, you can compare the effects of market volatilities on Pharvaris and Gilead Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Gilead Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Gilead Sciences.

Diversification Opportunities for Pharvaris and Gilead Sciences

-0.83

Correlation Coefficient

Pharvaris  Gilead Sciences

Pay attention - limited upside

The 3 months correlation between Pharvaris and Gilead is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Gilead Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gilead Sciences and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Gilead Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gilead Sciences has no effect on the direction of Pharvaris i.e., Pharvaris and Gilead Sciences go up and down completely randomly.

Pair Corralation between Pharvaris and Gilead Sciences

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the Gilead Sciences. In addition to that, Pharvaris is 1.87 times more volatile than Gilead Sciences. It trades about -0.09 of its total potential returns per unit of risk. Gilead Sciences is currently generating about 0.22 per unit of volatility. If you would invest  9,137  in Gilead Sciences on December 30, 2024 and sell it today you would earn a total of  2,042  from holding Gilead Sciences or generate 22.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Pharvaris BV  vs.  Gilead Sciences

Pharvaris BV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Gilead Sciences

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating essential indicators, Gilead Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pharvaris and Gilead Sciences

The main advantage of trading using opposite Pharvaris and Gilead Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Gilead Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gilead Sciences will offset losses from the drop in Gilead Sciences' long position.

The idea behind Pharvaris BV and Gilead Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.